Abhinna Mohanty Sundar

Abhinna Mohanty Sundar

Active Director Director DIN 00007995
DIN 00007995 First appointment May 2002 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since May 2002
Shareholding value •••• Premium profile

About Abhinna Mohanty Sundar

Data last updated:

Abhinna Mohanty Sundar is a Director at Marksans Pharma Limited (since 2019), Director at Ssb Seva Kartavya Private Limited (since 2014) and Director at Rytus Healthcare Private Limited (since 2011). The companies operate in Pharma, Other Industry and Healthcare. The largest current company by reported revenue is Marksans Pharma Limited at ₹3,033 Cr (FY 2026). Earlier, Abhinna Mohanty Sundar was a Whole-Time Director at Glenmark Pharmaceuticals Limited (2002–2011) and Director at Rytus Therapeutics Limited (from 2011).

DIN 00007995
Primary Designation Director
Industry Pharma
First Appointment 16 May 2002
Oldest Company Age 34 yrs
Largest company Marksans Pharma Limited · ₹3,033 Cr (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Marksans Pharma Limited L24110MH1992PLC066364
Director11 Jul 20191992₹3,033 Cr (FY 2026)Active
Ssb Seva Kartavya Private Limited U88900MH2014PTC255782
Director01 Jul 20142014Active
Rytus Healthcare Private Limited U88900MH2011PTC219910
Director18 Jul 20112011Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Glenmark Pharmaceuticals Limited L24299MH1977PLC019982
Whole-Time Director16 May 20021977₹17,443 Cr (FY 2026)Active
Rytus Therapeutics Limited U24100MH2011PLC213828
Director21 Feb 20112011₹1.42 Cr (FY 2015)Under Cirp

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Abhinna Mohanty Sundar

Directorship timeline

Open interactive timeline →
Marksans Pharma Limited
Rytus Therapeutics Limited
Rytus Healthcare Private Limited
Ssb Seva Kartavya Private Limited
Premium access

Shareholding and investment profile for Abhinna Mohanty Sundar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhinna Mohanty Sundar

Abhinna Mohanty Sundar currently holds 3 directorships: Marksans Pharma Limited (Director, since 11 Jul 2019, revenue ₹3,033 Cr (FY 2026)); Ssb Seva Kartavya Private Limited (Director, since 01 Jul 2014); Rytus Healthcare Private Limited (Director, since 18 Jul 2011).

Abhinna Mohanty Sundar was first appointed on 16 May 2002 as Whole-Time Director at Glenmark Pharmaceuticals Limited. The most recent appointment on record is 11 Jul 2019 at Marksans Pharma Limited.

Abhinna Mohanty Sundar held 2 earlier board appointments: Glenmark Pharmaceuticals Limited (Whole-Time Director, 16 May 2002 to 10 May 2011); Rytus Therapeutics Limited (Director, from 21 Feb 2011).

The current boards of Abhinna Mohanty Sundar's companies include Digant Mahesh Parikh (Marksans Pharma Limited), Harshavardhan Panigrahi (Marksans Pharma Limited), Jitendra Mahabirprasad Sharma (Marksans Pharma Limited), Mark Saldanha (Marksans Pharma Limited), Sandra Saldanha (Marksans Pharma Limited), Shailaja Vardhan (Marksans Pharma Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available